Search research articles
Contact Us
Filters
Showing results (141-150 of 233) with videos related to
Page
of 24
Sort By:
Plos Currents
|
December 6, 2011
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
Ray Dorsey, Kevin Biglan, Shirley Eberly, et al.
The Lancet. Neurology
|
October 25, 2020
Patient-centred management of Parkinson's disease - Authors' reply
Bastiaan R Bloem, Emily J Henderson, E Ray Dorsey, et al.
Psychiatric Services (Washington, D.C.)
|
January 16, 2013
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
Rachel Kornfield, Sydeaka Watson, Ashley S Higashi, et al.
JAMA
|
January 14, 2010
Funding of US biomedical research, 2003-2008
E Ray Dorsey, Jason de Roulet, Joel P Thompson, et al.
Archives of Neurology
|
December 10, 2008
Communicating clinical trial results to research participants
E Ray Dorsey, Christopher A Beck, Mary Adams, et al.
NPJ Digital Medicine
|
August 23, 2023
Using AI to measure Parkinson's disease severity at home
Md Saiful Islam, Wasifur Rahman, Abdelrahman Abdelkader, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study
E Ray Dorsey, Alicia F D Brocht, Paige E Nichols, et al.
Frontiers in Neurology
|
February 7, 2024
Digital assessment of speech in Huntington disease
Adonay S Nunes, Meghan Pawlik, Ram Kinker Mishra, et al.
Academic Pediatrics
|
February 14, 2012
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010
Craig F Garfield, E Ray Dorsey, Shu Zhu, et al.
Digital Health
|
June 27, 2018
Virtual research visits and direct-to-consumer genetic testing in Parkinson's disease
E Ray Dorsey, Kristin C Darwin, Samara Mohammed, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 233) with videos related to
Sort By:
Page
of 24
Plos Currents
|
December 6, 2011
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
Ray Dorsey, Kevin Biglan, Shirley Eberly, et al.
The Lancet. Neurology
|
October 25, 2020
Patient-centred management of Parkinson's disease - Authors' reply
Bastiaan R Bloem, Emily J Henderson, E Ray Dorsey, et al.
Psychiatric Services (Washington, D.C.)
|
January 16, 2013
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
Rachel Kornfield, Sydeaka Watson, Ashley S Higashi, et al.
JAMA
|
January 14, 2010
Funding of US biomedical research, 2003-2008
E Ray Dorsey, Jason de Roulet, Joel P Thompson, et al.
Archives of Neurology
|
December 10, 2008
Communicating clinical trial results to research participants
E Ray Dorsey, Christopher A Beck, Mary Adams, et al.
NPJ Digital Medicine
|
August 23, 2023
Using AI to measure Parkinson's disease severity at home
Md Saiful Islam, Wasifur Rahman, Abdelrahman Abdelkader, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study
E Ray Dorsey, Alicia F D Brocht, Paige E Nichols, et al.
Frontiers in Neurology
|
February 7, 2024
Digital assessment of speech in Huntington disease
Adonay S Nunes, Meghan Pawlik, Ram Kinker Mishra, et al.
Academic Pediatrics
|
February 14, 2012
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010
Craig F Garfield, E Ray Dorsey, Shu Zhu, et al.
Digital Health
|
June 27, 2018
Virtual research visits and direct-to-consumer genetic testing in Parkinson's disease
E Ray Dorsey, Kristin C Darwin, Samara Mohammed, et al.
Page
of 24